pSivida's Retisert to be co-promoted in the US

Shares in Western Australia's biggest biotechnology stock, pSivida Ltd, have risen 7 per cent following news that its Retisert product, licensed to Bausch & Lomb, will be co-promoted in the United States by Novartis Ophthalmics.


(existing subscribers)

The password field is case sensitive.
Request new password

Add your comment

BNiQ Disclaimer